Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 1/2009

01-02-2009 | Original Article

Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer

Authors: Makiko Ono, Masashi Ando, Mayu Yunokawa, Eriko Nakano, Kan Yonemori, Koji Matsumoto, Tsutomu Kouno, Chikako Shimizu, Kenji Tamura, Noriyuki Katsumata, Yasuhiro Fujiwara

Published in: International Journal of Clinical Oncology | Issue 1/2009

Login to get access
Metadata
Title
Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer
Authors
Makiko Ono
Masashi Ando
Mayu Yunokawa
Eriko Nakano
Kan Yonemori
Koji Matsumoto
Tsutomu Kouno
Chikako Shimizu
Kenji Tamura
Noriyuki Katsumata
Yasuhiro Fujiwara
Publication date
01-02-2009
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 1/2009
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-008-0797-8

Other articles of this Issue 1/2009

International Journal of Clinical Oncology 1/2009 Go to the issue

Original Article

Retrospective analysis of efficacy and safety of amrubicin in refractory and relapsed small-cell lung cancer

Review Article

Current status and perspectives of brachytherapy for breast cancer

Review Article

Current status and perspectives of brachytherapy for head and neck cancer

Case Report

Juvenile granulosa cell tumor of the ovary presenting with pleural effusion and ascites

Original Article

Phase I study of daily S-1 combined with weekly irinotecan in patients with advanced non-small cell lung cancer

Case Report

Alpha-fetoprotein (AFP)-producing ovarian tumor in an elderly woman
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits